Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Feb 1;59(2):e26-7.
doi: 10.1097/QAI.0b013e31823e2d2b.

Reverse transcriptase substitution at codons 208 and 228 among treatment-experienced HIV-1 subtype-C-infected Indian patients is strongly associated with thymidine analogue mutations

Shanmugam Saravanan, Vidya Madhavan, Sunil S Solomon, Rami Kantor, David Katzenstein, Sathasivam Sivamalar, Nagalingeswaran Kumarasamy, Davey M Smith, Kenneth H Mayer, Suniti Solomon, Pachamuthu Balakrishnan

Reverse transcriptase substitution at codons 208 and 228 among treatment-experienced HIV-1 subtype-C-infected Indian patients is strongly associated with thymidine analogue mutations

Shanmugam Saravanan et al. J Acquir Immune Defic Syndr. .

Abstract

In HIV-1 subtype C infected populations in south India, we searched for novel mutations associated with failing antiretroviral therapy that included nucleoside reverse transcriptase (RT) inhibitors. HIV-1 RT sequences were generated from treated and untreated groups and each nucleotide position was analysed with appropriate corrections for multiple testing. We found that nonsynonymous mutations at positions 208 and 228 were strongly associated with the presence of thymidine analogue mutations in the treated group, and were not present at all in the naïve group. The role of these substitutions on treatment outcomes and the evolution of drug resistance in HIV-1 subtype-C infected populations warrant further investigation.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: None declared.

Similar articles

See all similar articles

References

    1. Preston BD, Poiesz BJ, Loeb LA. Fidelity of HIV- 1 reverse transcriptase. Science. 1988;242:1168–71. - PubMed
    1. Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature. 1995;373:117–22. - PubMed
    1. Hu WS, Temin HM. Genetic consequences of packaging two RNA genomes in one retroviral particle: pseudodiploidy and high rate of genetic recombination. Proc Natl Acad Sci. 1990;87:1556–60. - PMC - PubMed
    1. Boucher CA, O’Sullivan E, Mulder JW, et al. Ordered appearance of zidovudine resistance mutations during treatment of 18 human immunodeficiency virus-positive subjects. J Infect Dis. 1992;165:105–10. - PubMed
    1. Sturmer M, Staszewski S, Doerr HW, Larder B, Bloor S, Hertogs K. Correlation of phenotypic zidovudine resistance with mutational patterns in the reverse transcriptase of human immunodeficiency virus type 1: interpretation of established mutations and characterization of new polymorphisms at codons 208, 211, and 214. Antimicrob Agents Chemother. 2003;47:54–61. - PMC - PubMed

Publication types